CD31 exhibits a distinct advantage over CD34, as it generates less background staining by predominantly highlighting endothelial-lined tumor emboli, thereby facilitating the more straightforward identification of tumor cells invading the vasculature [39,40]. This evidence concerns the gene PECAM1 and neoplasm.